Identification of a Potent and Selective GPR4 Antagonist as a Drug Lead for the Treatment of Myocardial InfarctionHayato Fukuda, Satoshi Shuto, Chihiro Mogi et al.|ACS Medicinal Chemistry Letters|2016Cited by 59
Anti‐neovascular therapy by liposomal DPP‐CNDAC targeted to angiogenic vesselsTomohiro Asai, Naoto Oku, Akira Matsuda et al.|FEBS Letters|2002Cited by 55
Characterization of Imidazopyridine Compounds as Negative Allosteric Modulators of Proton-Sensing GPR4 in Extracellular Acidification-Induced ResponsesAyaka Tobo, Fumikazu Okajima, Masayuki Tobo et al.|PLoS ONE|2015Cited by 43
Proceedings: Pharmacological profile of 6-o-chlorophenyl-8-ethyl-1-methyl-4H-s-triazolo(3,2-c)thieno(2,3-e)(1,4)diazepine(Y-7131).Makoto Nakanishi, Toshio Fukuda, T Kenjo et al.|PubMed|1974Cited by 3